EQL Pharma AB Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022
November 11, 2022 at 02:00 am EST
EQL Pharma AB (publ) reported earnings results for the second quarter and six months ended September 30, 2022. For the second quarter, the company reported sales was SEK 73.29 million compared to SEK 52.55 million a year ago. Net income was SEK 7.46 million compared to SEK 5.35 million a year ago. Basic earnings per share from continuing operations was SEK 0.26 compared to SEK 0.18 a year ago.
For the six months, sales was SEK 119.39 million compared to SEK 89.12 million a year ago. Net income was SEK 14.85 million compared to SEK 7.85 million a year ago. Basic earnings per share from continuing operations was SEK 0.51 compared to SEK 0.27 a year ago.